Inhibition of cell-cycle progression in human colorectal carcinoma Lovo cells by andrographolide

Chemico-Biological Interactions

Volumn 174, Issue 3, 2008, Pages 201-210

  Shi, Ming Der ^a,b   Lin, Hui Hsuan ^a   Lee, Yi Che ^a   Chao, Jian Kang ^b   Lin, Rong An ^b   Chen, Jing Hsien ^a  

^a CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^b Yongkang Veterans Hospital   (Taiwan)

Author keywords

Andrographolide; Cdk; Cell cycle arrest; Cyclin; Human colorectal carcinoma; Rb

Indexed keywords

ANDROGRAPHIS PANICULATA EXTRACT; ANDROGRAPHOLIDE; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; PROTEIN P16; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

ANDROGRAPHIS PANICULATA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER GROWTH; CAPILLARY ELECTROPHORESIS; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN LOVO; COLORECTAL CARCINOMA; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; PROTEIN PHOSPHORYLATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; E2F1 TRANSCRIPTION FACTOR; HUMANS; NEOPLASM PROTEINS; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53;

ANDROGRAPHIS PANICULATA;

EID: 48849109817     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.06.006     Document Type: Article

References (43)

1. Zhao J., Yang G., Liu H., Wang D., Song X., and Chen Y. Determination of andrographolide, deoxyandrographolide and neoandrographolide in the Chinese herb Andrographis paniculata by micellar electrokinetic capillary chromatography. Phytochem. Anal. 13 (2002) 222-227
2. Shen Y.C., Chen C.F., and Chiou W.F. Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effect. Br. J. Pharmacol. 135 (2002) 399-406
3. Shen Y.C., Chen C.F., and Chiou W.F. Suppression of rat neutrophil reactive oxygen species production and adhesion by the diterpenoid lactone andrographolide. Planta Med. 66 (2000) 314-317
4. Xia Y.F., Ye B.Q., Li Y.D., Wang J.G., He X.J., Lin X., Yao X., Ma D., Slungaard A., Hebbel R.P., Key N.S., and Geng J.G. Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. J. Immunol. 173 (2004) 4207-4217
5. Amroyan E., Gabrielian E., Panossian A., Wikman G., and Wagner H. Inhibitory effect of andrographolide from Andrographis paniculata on PAF-induced platelet aggregation. Phytomedicine 6 (1999) 27-31
6. Shukla B., Visen P.K.S., Patnaik G.K., and Dhawan B.N. Choleretic effect of andrographolide in rats and guinea pigs. Planta Med. 58 (1992) 146-149
7. Trivedi N.P., Rawal U.M., and Patel B.P. Hepatoprotective effect of andrographolide against hexachlorocyclohexane-induced oxidative injury. Integr. Cancer Ther. 6 (2007) 271-280
8. Basak A., Cooper S., Roberge A.G., Banik U.K., Chretien M., and Seidah N.G. Inhibition of proprotein convertases-1, -7 and furin by diterpines of Andrographis paniculata and their succinoyl esters. Biochem. J. 338 (1999) 107-113
9. Reddy V.L., Reddy S.M., Ravikanth V., Krishnaiah P., Goud T.V., Rao T.P., Ram T.S., Gonnade R.G., Bhadbhade M., and Venkateswarlu Y. A new bis-andrographolide ether from Andrographis paniculata nees and evaluation of anti-HIV activity. Nat. Prod. Res. 19 (2005) 223-230
10. Rajagopal S., Ajaya K.R., Devi D.S., Satyanarayana C., and Rajagopalan R. Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata. J. Expt. Ther. Onc. 3 (2003) 147-158
11. Srinivasa R.J., Hamzah A.S., Saad M.S., Lajis N.H., Stevens M.F.G., and Stanslas J. Semisynthesis and cytotoxic activities of andrographolide analogues. J. Enzyme Inhib. Med. Chem. 21 (2006) 145-155
12. Jada S.R., Subur G.S., Matthews C., Hamzah A.S., Lajis N.H., Saad M.S., Stevens M.F., and Stanslas J. Semisynthesis and in vitro anticancer activities of andrographolide analogues. Phytochemistry 68 (2007) 904-912
13. MacLachian T.K., Sang N., and Giordano A. Cyclins, Cyclin-dependent kinases and Cdk inhibitors: implications in cell cycle control and cancer. Crit. Rev. Eukaryot. Gene Expr. 5 (1995) 127-156
14. Spataro V. Recent advances in the molecular genetics of cancer. Ann. Oncol. 9 (1998) 23-29
15. Pardee A.B. G1 events and regulation of cell proliferation. Science 246 (1989) 603-608
16. Weinberg R.A. The retinoblastoma protein and cell cycle control. Cell 81 (1995) 323-330
17. Nevins J.R., Leone G., DeGregori J., and Jakoi L. Role of the Rb/E2F pathway in cell growth control. J. Cell. Physiol. 173 (1997) 233-236
18. Wang J.Y., Knudsen E.S., and Welch P.J. The retinoblastoma tumor suppressor protein. Adv. Cancer Res. 64 (1994) 25-85
19. Izumi M., Yokoi M., Nishikawa N.S., Miyazawa H., Sugino A., Yamagishi M., Yamaguchi M., Matsukage A., Yatagai F., and Hanaoka F. Transcription of the catalytic 180-kDa subunit gene of mouse DNA polymerase alpha is controlled by E2F, an Ets-related transcription factor, and Sp1. Biochim. Biophys. Acta 24 (2000) 341-352
20. Hunter T. Breaking the cycle. Cell 75 (1993) 839-841
21. Peters M., and Herskowitz I. Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 79 (1994) 181-184
22. Hall M., Bates S., and Peters G. Evidence for different modes of action of Cyclin-dependent kinase inhibitors p15 and p16 that bind to kinases p21, and p27 bind to Cyclins. Oncogene 11 (1995) 1581-1588
23. Tanigawa S., Fujii M., and Hou D.X. Stabilization of p53 is involved in quercetin-induced cell cycle arrest and apoptosis in HepG2 cells. Biosci. Biotechnol. Biochem. 72 (2008) 797-804
24. Chiu L.C., and Wan J.M. Induction of apoptosis in HL-60 cells by eicosapentaenoic acid (EPA) is associated with downregulation of bcl-2 expression. Cancer Lett. 145 (1999) 17-27
25. Chan F.L., Choi H.L., Chen Z.Y., Chan P.S., and Huang Y. Induction of apoptosis in prostate cancer cell lines by a flavonoid, baicalin. Cancer Lett. 160 (2000) 219-228
26. Kader F., Rovel B., Girardin M., and Metche M. Fractionation and identification of the phenolic compounds of Highbush blueberries (Vaccinium corymbosum L.). Food Chem. 55 (1996) 35-40
27. Panossian A., Hovhannisyan A., Mamikonyan G., Abrahamian H., Hambardzumyan E., Gabrielian E., Goukasova G., Wikman G., and Wagner H. Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination Kan Jang in rats and human. Phytomedicine 7 (2000) 351-364
28. Cheung H.Y., Cheung S.H., Li J., Cheung C.S., Lai W.P., Fong W.F., and Leung F.M. Andrographolide isolated from Andrographis paniculata induces cell cycle arrest and mitochondrial-mediated apoptosis in human leukemic HL-60 cells. Planta Med. 71 (2005) 1106-1111
29. Satyanarayana C., Deevi D.S., Rajagopalan R., Srinivas N., and Rajagopal S. DRF 3188 a novel semi-synthetic analog of andrographolide: cellular response to MCF 7 breast cancer cells. BMC Cancer 4 (2004) 26-33
30. Li J., Cheung H.Y., Zhang Z., Chan G.K., and Fong W.F. Andrographolide induces cell cycle arrest at G2/M phase and cell death in HepG2 cells via alteration of reactive oxygen species. Eur. J. Pharmacol. 568 (2007) 31-44
31. Lomlim L., Jirayupong N., and Plubrukarn A. Heat-accelerated degradation of solid-state andrographolide. Chem. Pharm. Bull. 51 (2003) 24-26
32. Yanfang Z., Xingping L., Zongde Z., Liren C., and Yongmin L. Simultaneous determination of andrographolide and dehydroandrographolide in Andrographis paniculata and Chinese medicinal preparations by microemulsion electrokinetic chromatography. J. Pharm. Biomed. Anal. 40 (2006) 157-161
33. Kim Y.S., and Milner J.A. Targets for indole-3-carbinol in cancer prevention. J. Nutr. Biochem. 16 (2005) 65-73
34. Srivastava R.K., Chen Q., Siddiqui I., Sarva K., and Shankar S. Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21(/WAF1/CIP1). Cell Cycle 6 (2007) 2953-2961
35. Aggarwal B.B., Banerjee S., Bharadwaj U., Sung B., Shishodia S., and Sethi G. Curcumin induces the degradation of CyclinE expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. Biochem. Pharmacol. 73 (2007) 1024-1032
36. Nihal M., Ahmad N., Mukhtar H., and Wood G.S. Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma. Int. J. Cancer 114 (2005) 513-521
37. Agarwal C., Sharma Y., and Agarwal R. Anticarcinogenic effect of a polyphenolic fraction isolated from grape seeds in human prostate carcinoma DU145 cells: modulation of mitogenic signaling and cell cycle regulators and induction of G1 arrest and apoptosis. Mol. Carcinog. 28 (2000) 129-138
38. Katdare M., Osborne M.P., and Telang N.T. Inhibition of aberrant proliferation and induction of apoptosis in pre-neoplastic human mammary epithelial cells by natural phytochemicals. Oncol. Rep. 5 (1998) 311-315
39. Taylor W.R., and Stark G.R. Regulation of the G2/M transition by p53. Oncogene 20 (2001) 1803-1815
40. Ferreira C.G., Tolis C., and Giaccone G. p53 and chemosensitivity. Ann. Oncol. 10 (1999) 1011-1021
41. Sauer H., Wartenberg M., and Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol. Biochem. 11 (2001) 173-186
42. Woo A.Y., Waye M.M., Tsui S.K., Yeung S.T., and Cheng C.H. Andrographolide up-regulates cellular-reduced glutathione level and protects cardiomyocytes against hypoxia/reoxygenation injury. J. Pharmacol. Exp. Ther. 325 (2008) 226-235
43. Chang K.T., Lii C.K., Tsai C.W., Yang A.J., and Chen H.W. Modulation of the expression of the pi class of glutathione S-transferase by Andrographis paniculata extracts and andrographolide. Food Chem. Toxicol. 46 (2008) 1079-1088